Also In This Section
  • Categories

  • Recent News

  • Category: BDH

    Hoda Hatoum to Present Biological Sciences Seminar September 16


    by Biological Sciences

    Hoda Hatoum (BioMed, ICC-BDH) will present Thursday (Sept. 16) at 3 p.m. as part of the Biological Sciences Seminar Series. The presentation will be held virtually on Zoom.

    From the abstract: Transcatheter aortic valve replacement (TAVR) is a non-invasive valve replacement therapy that has been recently FDA approved for low-risk patients. Despite the importance of this therapy, TAVR has been associated with several adverse effects and long-term adverse outcomes such as short durability and thrombus formation. Several clinical studies showed that the incidence of leaflet thrombosis (LT) post-TAVR ranges between 8 to 24% overall, with increasing incidences from 30 day to 1-year timepoints, which makes leaflet thrombosis a highly important concern. … The purpose of this study is to present a semi-empirical, mathematical model that links patient-specific anatomic, valve, and flow parameters to predict leaflet thrombosis. This tool will be essential in clinical pre-procedural planning. To this end, we used a combination of experimental, analytical, and computational fluid dynamic studies along with patient-specific data.


    Jingfeng Jiang Awarded $347K NIH R-D Grant

    Jingfeng Jiang (BioMed/HRI) is the principal investigator on a project that has a received a $346,966 research and development grant from the National Institutes of Health.

    The project is titled “Personalized Management of Intracranial Aneurysms Using Computer-aided Analytics.”

    Jinshan Tang (AC/HRI) is a co-PI on this potential four-year project, which could total $1,349,106.